newsfilter
← Latest News
GlobeNewswire·

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

Heart-2 clinical trial of VERVE-102 enrolling in the U.K. and Canada; Clinical Trial Application cleared in Australia Heart-2 and PCSK9 program data update planned for first half of 2025 Phase 1b clinical trial